Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular epidemiology of vancomycin resistant enterococci collected from 9 hospitals in Beijing, China: a multicenter study.

Frontiers in cellular and infection microbiology·2026
Same author

CD11c+ CD8 T cells cause IFN-γ-dependent autoimmune neuroinflammation that is restrained by PD-1 signaling.

JCI insight·2026
Same author

A Dual-Functional Biohybrid Nanorobot to Synergistically Eradicate Biofilm and Degrade Antibiotic Resistance Genes.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Deep learning-enhanced NLOS NOMA-VLC system based on chirp spread spectrum modulation.

Optics express·2026
Same author

Association of Visceral Fat Mass Index with Diabetes and Vascular Complications: NHANES 2011-2018 Cross-Sectional Study.

Health data science·2026
Same author

Evolution of phage tail fiber proteins to counter bacterial resistance and improve biocontrol efficacy in plant disease models.

Microbiological research·2026

Related Experiment Video

Updated: Jun 30, 2026

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
08:57

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin

Published on: March 26, 2015

Cellular remyelinating therapy in multiple sclerosis.

Jingxian Yang1, Abdolmohamad Rostami, Guang-Xian Zhang

  • 1Department of Neurology, Thomas Jefferson University, Philadelphia, PA 19107, USA.

Journal of the Neurological Sciences
|September 26, 2008
PubMed
Summary
This summary is machine-generated.

Cell transplantation offers a promising strategy for remyelination in multiple sclerosis (MS). Understanding the mechanisms of myelin repair, such as immunomodulation and cell replacement, is key to advancing these therapies.

More Related Videos

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

Related Experiment Videos

Last Updated: Jun 30, 2026

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
08:57

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin

Published on: March 26, 2015

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

Area of Science:

  • Neuroscience
  • Immunology
  • Regenerative Medicine

Background:

  • Multiple sclerosis (MS) is characterized by demyelination in the central nervous system (CNS).
  • Current therapeutic strategies aim to address the autoimmune and neurodegenerative aspects of MS.
  • Remyelination is a crucial process for restoring neurological function.

Purpose of the Study:

  • To review myelin-forming cell types for transplantation in CNS demyelinating diseases.
  • To explore the mechanisms underlying cell-based remyelination therapies.
  • To forecast future directions in remyelination research.

Main Methods:

  • Literature review of recent experimental findings on cell transplantation for remyelination.
  • Analysis of proposed mechanisms of remyelinating effects.
  • Speculative outlook on the evolution of cell-based therapies.

Main Results:

  • Cell transplantation, using myelinogenic or neural stem cells, shows potential for remyelination.
  • Potential mechanisms include immunomodulation, direct cell replacement, and promotion of endogenous repair.
  • Identifying these mechanisms is vital for optimizing cell-based therapeutic approaches.

Conclusions:

  • Cell-based therapies hold significant promise for treating MS by promoting remyelination.
  • Further research into the precise mechanisms of action will refine therapeutic strategies.
  • The future of MS treatment may involve advanced cell transplantation techniques for CNS repair.